News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients Caitlin E. Cox August 13, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Daily News Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3 Yael L. Maxwell January 15, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Conference News ESC 2024 MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority Shelley Wood September 01, 2024
News Daily News Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2 Shelley Wood July 09, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction Michael O'Riordan May 06, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024
News Opinion Off Script My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration Benoy Shah, MBBS, MD(Res) January 24, 2024
News Conference News TCT 2023 SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC Yael L. Maxwell October 30, 2023
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Daily News US and European Valvular Guidelines Mostly Concordant, Analysis Finds L.A. McKeown August 21, 2023